Get started
Author

Sakshi Sachdeva

ORCID: 0000-0003-0901-3716
Observed ORCID: 0000-0003-0901-3716
OpenAlex ID: A5011657489
Adenosine and its receptors as therapeutic targets: An overview
2012 · Sakshi Sachdeva, Monika Gupta · Saudi Pharmaceutical Journal · 137
PDF
Peptides as ‘Drugs’: The Journey so Far
2016 · Sakshi Sachdeva · International Journal of Peptide Research and Therapeutics · 72
Measurement of Corporate Social Responsibility of Financial Companies in the Indian Context
2023 · Sakshi Sachdeva, Latha Ramesh, et al. · Indian Journal of Finance · 8
PDF
Synthesis, Evaluation and in silico studies of 1,8-Naphthyridine derivatives against antimicrobial activity
2015 · Sakshi Sachdeva, Sonam Bhatia, et al. · Journal of Applied Pharmaceutical Science · 5
PDF
Monitoring abnormality in returns of companies around corporate social responsibility esg-rating
2021 · Sakshi Sachdeva · ACADEMICIA An International Multidisciplinary Research Journal · 2
Aligning Investments with Values: Creating Portfolios Based on Corporate Social Responsibility and NIM
2024 · Sakshi Sachdeva, Latha Ramesh · Contemporary studies in economic and financial analysis · 1
Impact of moral and exchange capital on media favourability of financial companies in India
2025 · Sakshi Sachdeva, Latha Ramesh · Social Responsibility Journal
Investor Perspectives: Evaluating the Impact of CSR on Excess Returns in Financial Companies
2024 · Sakshi Sachdeva, Latha Ramesh · Springer proceedings in business and economics
Monitoring Abnormality in Returns Around Credit Rating Announcements
2013 · Amitesh Kapoor, Sakshi Sachdeva, et al. · SSRN Electronic Journal
Aligning Investments with Values: Creating Portfolios Based on Corporate Social Responsibility and NIM
· Sakshi Sachdeva, Latha Ramesh · RePEc: Research Papers in Economics
Works count: 10
Citation count: 225
H-index: 4
I10-index: 2
Year
Topic
Type